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Regulated expression of positive and negative regulatory factors controls the extent and 
duration of T cell adaptive immune response preserving the organism’s integrity. Calreticu-
lin (CRT) is a major Ca2+ buffering chaperone in the lumen of the endoplasmic reticulum. 
Here we investigated the impact of CRT defi  ciency on T cell function in immunodefi  cient 
mice reconstituted with fetal liver crt  −/− hemopoietic progenitors. These chimeric mice 
displayed severe immunopathological traits, which correlated with a lower threshold of 
T cell receptor (TCR) activation and exaggerated peripheral T cell response to antigen with 
enhanced secretion of infl  ammatory cytokines. In crt  −/− T cells TCR stimulation induced 
pulsatile cytosolic elevations of Ca2+ concentration and protracted accumulation of nuclear 
factor of activated T cells in the nucleus as well as sustained activation of the mitogen-
activated protein kinase pathways. These observations support the hypothesis that CRT-
dependent shaping of Ca2+ signaling critically contributes to the modulation of the T cell 
adaptive immune response.
T cell interaction with antigen-presenting cells 
in antimicrobial immune response stimulates 
a cascade of TCR-driven signal transduction 
events, which eventually results in clonal ex-
pansion, activation of eff  ector functions, and 
generation of memory. Positive and negative 
regulatory feedback loops infl  uence stimulation 
threshold as well as propagation and persistence 
of signals in the various phases of the response 
(1). The correct regulation of all elements in-
volved in the T cell response to antigen ensures 
appropriate T cell expansion, diff  erentiation, and 
homeostasis. Indeed, defects in negative regula-
tory molecules, such as phosphatases (2, 3), E3 
ubiquitin ligases (4, 5), cell surface receptors (6), 
and transcription factors (7, 8), contribute to the 
development of immunopathology. Defects in 
the induction of apoptosis were shown to aff  ect 
the deletion of autoreactive cells in the thymus, 
resulting in autoimmune pathology in the pe-
riphery (9). Apoptosis is also critical in deter-
mining the contraction of the immune response 
to a given pathogen (10). The identifi  cation of 
elements that selectively infl  uence the outcome 
of TCR stimulation at distinct phases of T cell 
development and diff  erentiation is of great im-
portance for understanding the functioning of 
the adaptive immune system.
A crucial signal for T cell response after ag-
onist binding to the TCR is the elevation of 
intracellular free Ca2+ ([Ca2+]i), which is con-
tributed by both release from intracellular stores 
and infl  ux from extracellular space through 
Ca2+ release–activated Ca2+ channels in the 
plasma membrane (11). Moreover, diff  erent 
amplitudes and frequencies of [Ca2+]i eleva-
tions in the lymphocyte were shown to diff  er-
entially regulate activation of transcription 
factors crucially involved in the immune re-
sponse (12, 13). Among these factors, NFAT is 
dephosphorylated and translocated to the nu-
cleus upon activation of the phosphatase calci-
neurin by [Ca2+]i increase (14). Members of 
the NFAT family were shown to participate 
both as positive as well as negative regulators of 
the T cell response to antigen (15).
Calreticulin (CRT) is a Ca2+ binding 
chaperone protein predominantly localized 
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in the ER where it assists the folding of glycoproteins (16).   
The protein may be divided into three structural and func-
tional domains: the NH2-terminal N-domain, which is ex-
tremely conserved and likely participates in the folding of 
specifi  c substrates and, together with the extended proline-
rich P-domain, has a lectin-like chaperone activity. The 
acidic COOH-terminal C-domain with low affi   nity, high 
avidity for Ca2+ contributes to the Ca2+ storage capacity of 
the ER (17). The amount of CRT-bound Ca2+ in the ER 
may dramatically infl  uence the cell fate; e.g., overexpression 
of CRT leads to increased susceptibility to apoptotic stimuli 
(18), whereas CRT-defi  cient cells are more resistant to apop-
tosis (19). CRT defi  ciency in mice is embryonically lethal 
because of altered cardiac development, and the majority of 
crt−/− embryos die at day 12–13 of gestation (20). In embry-
onic crt−/− cardiomyocyte, defective Ca2+ release from the 
ER upon agonist stimulation results in defective calcineurin-
dependent activation of myocyte enhancer factor 2C and 
contributes signifi  cantly to embryonic lethality (21). Indeed, 
transgenic expression of a constitutively active isoform of cal-
cineurin in the hearth resumed myofi  brillogenesis in crt−/− 
embryos (22).
To study the impact of CRT defi  ciency on lymphocyte 
function we generated fetal liver chimeric mice by reconstitut-
ing RAG-2/common γ chain double knockout (DKO) mice 
with fetal liver hemopoietic progenitors (FLPs) from crt−/− em-
bryos. Crt−/− fetal liver chimeras displayed immunopathological 
traits that correlated with exaggerated responsiveness to TCR 
stimulation, increased cytokine production, reduced apoptosis, 
and altered regulation of signaling in peripheral T cells. These 
observations suggest that CRT plays a crucial role in regulating 
the eff  ector phase of the adaptive immune response.
RESULTS
Immunopathological phenotype of crt  −/− fetal liver chimeras
RAG/γ chain DKO mice reconstituted with crt−/− FLPs display 
alopecia and blepharitis starting at week 7 after reconstitution 
(Fig. 1 a). Histological analysis of the skin revealed epidermis 
hyperplasia and an infl  ammatory infi  ltrate (not depicted). An 
infl  ammatory infi  ltrate was also evident in the peribronchial 
space of the lung, whereas the thymus, gut, kidney, liver, and 
pancreas were histologically unaltered. Antinuclear, anti–dou-
ble-stranded DNA, and anti-cardiolipin antibodies were absent 
from the sera of both crt+/+ (n = 22) and crt−/− (n = 20) chi-
meras (see Supplemental Materials and methods, available at 
http://www.jem.org/cgi/content/full/jem.20051519/DC1); 
however, IgG1 and IgE serum levels were signifi  cantly increased 
in crt−/− chimeras (crt+/+, n = 26: IgG1 = 1.5 ± 0.7 mg/ml, 
IgE = 1.1 ± 2.4 μg/ml; crt−/−, n = 24: IgG1 = 5.8 ± 3.0 
mg/ml, P < 0.0001, IgE = 10.5 ± 14.5 μg/ml, P = 0.002). 
The immunopathology and higher immunoglobulin levels 
in crt−/− chimeric mice were dependent on T cells because 
crt−/−/cd3ε−/− DKO chimeras were healthy up to 20 wk af-
ter reconstitution and did not display signifi  cant diff  erences 
with respect to crt+/+/cd3ε−/− DKO chimeras in serum IgG1 
(crt+/+ = 4.6 ± 3.8 μg/ml, n = 4; crt−/− = 3.4 ± 2.9 μg/ml, 
n = 8) and IgE, which were undetectable. 20% of crt−/− 
mice   developed a wasting syndrome that correlated with a 
relative increase in the detection of TNF-α in the serum (Fig. 
1 b). Indeed, overproduction of TNF-α has been shown to be 
involved in the pathogenesis of diff  erent disease states, and the 
expression of a TNF-α transgene in T cells determined the de-
velopment of a wasting syndrome (23). Analysis of T cells from 
lymph nodes and spleen revealed an increase in the CD4/CD8 
ratio in crt−/− chimeras (Fig. 2 a). Absolute numbers of CD4 
cells in the spleen were not signifi  cantly increased (crt+/+ =
11.0 ± 5.8 × 106, n = 35; crt−/− = 10.8 ± 5.8 × 106, 
n = 39). Both CD4 and CD8 subsets displayed increased per-
centages of activated cells, as determined by CD69 and CD25 
expression (Fig. 2 b). In the CD4 subset, both CD25+69+ and 
CD25+69− cells were signifi   cantly increased in crt−/− ver-
sus crt+/+ chimeras (CD25+69+: crt−/−, 15.5 ± 5.3%, n = 4; 
crt+/+, 4.8 ± 1.1%, n = 5, P = 0.003; CD25+69−: crt−/−, 
12.3 ± 2.1%, n = 4; crt+/+, 7.4 ± 1.4%, n = 5, P = 0.004). 
Intracellular staining for IL-2, IFN-γ, and TNF-α of freshly 
isolated peripheral T cells treated with brefeldin A, ionomycin, 
and PMA revealed increased percentages of cells producing 
these cytokines (Fig. 2 c).
Figure 1.  Phenotype of chimeric mice. (a) RAG/γ chain DKO mice 
reconstituted with crt +/+ and crt −/− FLPs at weeks 12 (crt +/+), 8 (crt −/−, 
top right), 10 (crt −/−, bottom left), and 12 (crt −/−, bottom right) after 
reconstitution. (b) Relative distributions of chimeric mice with respect 
to phenotype (left) and detection of TNF-α in the serum (>2 pg/ml). 
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Thymocyte development in crt  −/− chimeric mice
Because pre-TCR (24) and αβTCR (25–27) signaling induce 
[Ca2+]i elevations during thymocyte development, we tested 
whether CRT defi  ciency interfered with T cell diff  erentiation 
in the thymus. Immature thymocyte subset representation did 
not reveal an altered pre-TCR signaling in crt−/− thymocyte 
(see Supplemental Results and Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20051519/DC1). Next, 
we checked whether CRT defi  ciency aff  ected positive selec-
tion of αβTCR+ CD4+8+ double positive (DP) cells. Cell 
recoveries (crt+/+: 45.8 ± 27.8 × 106, n = 40; crt−/−: 42.9 ±
26.6 × 106, n = 30) and CD4/CD8 ratios (crt+/+: 2.79 ± 
0.65, n = 24; crt−/−: 2.43 ± 0.97, n = 25) of thymi ana-
lyzed between weeks 6 and 20 after reconstitution were not 
signifi  cantly  diff   erent. Thymocyte subset distribution with 
respect to CD4 and CD8 expression revealed a modest but 
statistically signifi  cant reduction of the DP compartment with 
relative increases of both CD4 and CD8 single positive (SP) 
cells (Fig. S1). DP cell contraction was most severe in the 
atrophic thymi obtained from animals aff  ected by the wasting 
syndrome (not included in the statistical analysis) in which DP 
cells were undetectable. We imputed DP cell reduction in 
crt−/− chimeras to circulating proinfl  ammatory cytokines af-
fecting DP cell viability. Up-regulation of αβTCR and CD69 
in DP cells as well as CD69 expression in CD4+ and CD8+ 
SP cells were all unaff  ected, suggesting that positive selection 
was occurring analogously in crt−/− as well as crt+/+ thymocyte 
(Fig. S1). It was possible that a thymocyte expressing a given 
TCR responded diff  erently to positively selecting signals in the 
absence of CRT. Then, H-2b crt−/+ mice were crossed with 
H-2d mice transgenic for the I-Ad–restricted DO11.10 TCR 
specifi  c for the OVA peptide (OVAp) 323–339 (28). The 
crt−/+/DO11.10tg progeny was intercrossed and H-2b/d crt−/− 
as well as crt+/+/DO11.10tg embryos were identifi  ed. Analy-
sis of T cell development in fetal thymus organ culture with 
thymi from H-2d/b DO11.10tg crt−/− and crt+/+ embryos did 
not reveal diff  erences in CD69 expression in both DO11.10tg 
DP cells and DO11.10tg CD4+ SP cells (Fig. S1), implying 
unaltered positive selection of DO11.10tg thymocytes in the 
absence of CRT. CRT defi  ciency decreases the sensitivity 
of a cell to apoptosis (19); thus, we checked whether this be-
havior was also common to thymocytes undergoing negative 
selection in the thymus. To assess thymocyte sensitivity to 
apoptosis we analyzed in vivo deletion by endogenous supe-
rantigens and in vitro induction of apoptosis in diff  erent assays 
(see Supplemental Results and Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20051519/DC1). None 
of these experiments revealed a signifi  cant impairment of the 
clonal deletion process in crt−/− thymocytes. We concluded 
that CRT defi  ciency was not manifestly aff  ecting either pre-
TCR– or αβTCR-driven responses in the thymocyte.
Normal functional activity of T regulatory (T reg) cells 
from crt  −/− chimeras, but reduced sensitivity of crt  −/− T cells 
to T reg cell–mediated suppression
The CD4+25+ T reg cell subset exerts a crucial role in con-
trolling anti-self immune responses (29) as well as the extent 
of T cell eff  ector responses, thus inhibiting possible tissue 
damage resulting from antimicrobial immune responses (30). 
The abnormal activation of T cells in the periphery of crt−/− 
chimeras could be due to ineffi   cient function of the T reg cell 
subset. CD4+25+ cells were purifi  ed from crt−/− as well as 
crt+/+ chimeras and challenged for immunoregulatory compe-
tence in inhibition of the mitogenic response of naive T cells 
to CD3ε antibodies. The same effi   ciency in inhibiting the 
proliferative response of crt+/+ naive T cells was detected for 
Figure 2.  Increased CD4/CD8 ratio, augmented representations of 
activated T cells, and cytokine secretion by ex vivo crt  −/− T cells. 
(a) CD4/CD8 ratios in the spleen and lymph nodes. (b) Relative representa-
tions of CD69+ cells in CD4+ and CD8+ subsets (left) and CD25+ cells in 
CD4+ subset (right). Gray bars, crt +/+ chimeras; black bars, crt −/− chimeras. 
(c) Ex vivo cytokine secretion of CD4+ and CD8+ T cells. Intracellular staining 
for the indicated cytokine was performed on freshly isolated lymph node 
cells treated with PMA, ionomycin, and brefeldin A (see Materials and meth-
ods). This experiment is representative of six different mice per group.
Figure 3.  Effi  cient function of crt  −/− T reg cells and decreased 
sensitivity of crt  −/− naive T cells to T reg cell–mediated suppression. 
Inhibition of CD3ε mitogenic response of crt +/+ (■) and crt −/− (◆) naive 
T cells by purifi  ed CD4+CD25+ cells from crt +/+ (left) or crt −/− (right) 
chimeric mice. Values are means ± SD of three independent experiments.464  REGULATION OF T CELL ACTIVATION BY CALRETICULIN | Porcellini et al. 
both crt−/− and crt+/+ T reg cells, indicating that T reg cells 
were not intrinsically aff  ected by CRT defi  ciency. However, 
the proliferation of crt−/− naive T cells was less effi   ciently in-
hibited by T reg cells purifi  ed from both crt−/− and crt+/+ chi-
meras (Fig. 3), suggesting that crt−/− T cells were less susceptible 
to T reg cell–mediated suppression than crt+/+ T cells.
In vitro– and in vivo–enhanced responsiveness 
of crt  −/− naive T cells
To determine whether crt−/− T cells were more responsive to 
TCR triggering we purifi  ed CD4+CD44−CD25−CD62L+ 
naive T cells from chimeric mice. Both crt+/+ and crt−/− na-
ive T cells were stimulated with decreasing concentrations of 
immobilized CD3ε antibodies. Crt−/− naive T cells re-
sponded robustly to concentrations of CD3ε antibodies that 
were nonmitogenic for crt+/+ cells (Fig. 4 a). To analyze the 
impact of CRT defi  ciency on the T cell response to antigen, 
H-2b/d crt−/− and crt+/+/ DO11.10tg FLPs were used to 
  reconstitute H-2d RAG/γ chain DKO mice. Naive 
CD4+DO11.10tg T cells from the lymph nodes and spleens 
of reconstituted mice were sorted and stimulated in vitro 
with I-Ad DCs loaded with diff   erent concentrations of 
OVAp. Fig. 4 b shows that whereas DCs pulsed with 2 μM 
OVAp generated comparable responses in crt−/− versus crt+/+ 
cells, pulses with 0.2 μM OVAp generated robust prolifera-
tion of crt−/− but not crt+/+ T cells. To analyze the response 
of DO11.10tg cells in vivo, splenocytes from reconstituted 
mice containing 106 CD4+DO11.10tg T cells were labeled 
with CFSE and injected into H-2b/d mice. After 48 h mice 
were challenged with I-Ad DCs loaded with OVAp into the 
footpad. Inspection of the draining lymph nodes of mice 
adoptively transferred with crt−/− cells revealed more promi-
nent swelling than those of mice transferred with crt+/+ cells. 
Moreover, crt−/− DO11.10tg cells underwent more robust 
expansion and displayed increased cytokine secretion with 
respect to the crt+/+ counterpart (Fig. 4, c and d). These data 
demonstrate that naive T cells from crt−/− chimeras undergo 
exaggerated responses upon antigen encounter.
Increased representation in vivo and hyperresponsiveness 
of crt  −/− effector–memory T cells
Analysis of peripheral T cells for representation of eff  ec-
tor–memory cells as determined by the CD44+CD62L− 
phenotype revealed an increase of this subset in both CD4 
and CD8 crt−/− T cell populations (Fig. 5 a). To test whether 
eff  ector–memory T cells derived from crt+/+ and crt−/− fe-
tal liver   chimeras might diff  er in their activation thresh-
old and dependence on costimulation for proliferation and 
diff  er  entiation into cytokine-secreting cells, we isolated 
CD4+CD44+CD25−CD62L− cells from the spleen and 
lymph nodes. Purifi   ed cells were labeled with CFSE and 
stimulated for 16 h with immobilized CD3ε antibodies in 
the absence of costimulation as suboptimal stimulus. Stimu-
lated cells were cultured in medium alone or medium con-
taining IL-2, IL-7, or IL-15 and followed by analysis for cell 
division (31). Crt+/+ cells did not proliferate in response to 
suboptimal CD3 triggering, whereas the same stimulus was 
suffi   cient to determine signifi  cant expansion of crt−/− cells 
(Fig. 5 b). IL-2 and IL-7 further implemented this cell pro-
liferation, whereas IL-15 was without any eff  ect, as expected 
for murine CD4+ memory cells (32). Stimulation with CD3 
and CD28 antibodies for 40 h promoted increased re-
sponses in crt−/− eff  ector–memory T cells; nevertheless, we 
detected robust proliferation of both crt−/− and crt+/+ eff  ec-
tor–memory T cells that was not signifi  cantly infl  uenced by 
cytokine addition (Fig. 5 b). Analysis of CFSE dilution and 
annexin V staining at diff  erent times after CD3ε stimulation 
without CD28 revealed increased percentages of proliferat-
ing cells as well as reduced percentages of apoptotic cells in 
crt−/− samples when compared with crt+/+ samples. In con-
trast, no diff  erences between crt−/− and crt+/+ samples were 
Figure 4.  Enhanced in vitro and in vivo responsiveness of crt  −/− 
naive T cells. (a) [3H]thymidine incorporation in purifi  ed naive CD4+ 
T cells stimulated with decreasing doses of plate-bound CD3ε mAb. 
●, crt −/−; ■, crt +/+. cpm values (±SD) are from a single experiment 
representative of three. (b) DCs were loaded with the indicated concentra-
tions of OVAp and used to stimulate purifi  ed naive CD4+ cells from 
DO11.10tg crt +/+ (gray bars) and crt −/− (black bars) chimeras. The dis-
played results are representative of four different experiments. Similar 
proportions of TCR transgenic cells were present in both crt +/+ and 
crt −/− naive T cell suspensions in all experiments (from 75 to 90%). 
(c) CD4+DO11.10tg H-2d/b crt +/+ (gray bars) and crt −/− (black bars) cell 
re  coveries from draining lymph nodes of adoptively transferred H-2b/d 
mice immunized with OVAp-loaded DCs into the footpad at days 7 and 11 
from immunization. The inset shows two representative draining lymph 
nodes at day 11 from immunization. Bar, 0.5 cm. (d) Intracellular staining 
for the indicated cytokine versus CFSE dilution of electronically gated 
CD4+DO11.10tg H-2b/d cells from the draining lymph nodes of adoptively 
transferred H-2b/d mice immunized with OVAp-loaded DCs at day 7 after 
immunization. This experiment was repeated three times with at least two 
animals/groups/time points with comparable results.JEM VOL. 203, February 20, 2006  465
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detected when cells were stimulated with CD3ε and CD28 
antibodies (Fig. 5 c). Analysis of IL-2 secretion after sub-
optimal TCR stimulation revealed a prominent increase in 
crt−/− versus crt+/+ cells (Fig. 5 d). These results indicate that 
eff  ector–memory T cells from crt−/− chimeras display a lower 
activation threshold and less dependence on costimulation to 
mount a productive response. Furthermore, quantifi  cation of 
IL-4 in the supernatant of eff  ector–memory T cells stimu-
lated with CD3ε and CD28 antibodies revealed a prominent 
increase of IL-4 production in crt−/− cultures (Fig. 5 d).
Induction of unresponsiveness in crt  −/− T cells
Induction of T cell unresponsiveness or anergy is supposed to 
play an important role in maintaining peripheral tolerance 
(33). Anergy can be induced in vitro through a massive in-
crease in cytosolic Ca2+ before T cell stimulation (34). There-
fore, we tested whether sorted eff  ector–memory T cells from 
FLP chimeras became unresponsive to TCR stimulation after 
pretreatment with ionomycin (Supplemental Materials and 
methods). Fig. 6, a and b, shows the results of two indepen-
dent experiments in which either untreated or ionomycin-
pretreated cells were stimulated with CD3ε antibodies. Both 
cell proliferation scored by CFSE dilution or [3H]thymidine 
incorporation and IL-2 production in crt−/− cells were signif-
icantly inhibited by ionomycin pretreatment with a relative 
effi   ciency undistinguishable from that observed with crt+/+ 
cells. To further substantiate this phenomenon in vivo, we 
fed DO11.10tg mice with OVA (100 mg/day) for 5 d to as-
sess anergy induction, as described previously (34). Sorted 
CD4 cells from untreated or OVA-fed mice were stimulated 
in vitro with DCs pulsed with decreasing doses of OVAp. 
Fig. 6 c shows that both [3H]thymidine incorporation and 
IL-2 production were signifi   cantly reduced in crt−/− cells 
from OVA-fed animals, implying that unresponsiveness could 
be enforced in crt−/− cells.
Deregulated signal transduction in crt  −/− T cells
To investigate whether CRT defi  ciency aff  ected Ca2+ sig-
naling in T cells, sorted CD4+ eff  ector–memory cells were 
loaded with fura-2 and analyzed by single cell calcium im-
aging (Supplemental Materials and methods). Stimulation 
with CD3ε antibodies was followed by capacitive calcium 
entry in both crt−/− and crt+/+ cells, thus indicating that 
ER calcium release and Ca2+ release–activated Ca2+ channel 
activation function normally in both cell types. Interestingly, 
increased frequencies of responding crt−/− versus crt+/+ cells 
(48.4 ± 5%, n = 120 vs. 39.5 ± 4%, n = 156) were observed, 
indicating that the threshold for activation of individual cells 
may be lowered by CRT defi  ciency. Because ex vivo cells did 
not allow prolonged analyses, we performed a more detailed 
investigation of Ca2+ signaling with OVAp-specifi  c T helper 
clones derived from DO11.10tg chimeras. Three diff  erent 
clones for each group of crt−/− and crt+/+ chimeras stimu-
lated with CD3ε antibodies displayed increased frequencies 
Figure 5.  Augmented representation of effector–memory T cells in 
crt  −/− chimeras and in vitro responsiveness to suboptimal CD3𝗆 
stimulation. (a) Relative representations of CD44+CD62L− cells in CD4+ 
and CD8+ subsets. Gray bars, crt +/+ chimeras; black bars, crt −/− chimeras. 
(b) CFSE dilution in purifi  ed CD4+ effector–memory cells stimulated with 
CD3ε mAb for 16 h (top) and CD3ε+CD28 mAbs for 40 h (bottom) as 
detailed in Materials and methods. The addition of a particular cytokine is 
indicated on top of the relative histograms. Numbers indicate the abso- 
lute values of cells recovered within the marker limits in standardized 
acquisitions. (c) Relative representations at different time points of 
effector–memory T cells with diluted CFSE (i.e., proliferating; top) and 
cells positive for annexin V (bottom) upon stimulation with the indicated 
mAbs for the indicated times. (d) IL-2 and IL-4 concentrations in culture 
supernatants of effector–memory T cells stimulated with the indicated 
mAbs for the indicated times. Gray bars, crt +/+ chimeras; black bars, 
crt −/− chimeras.466  REGULATION OF T CELL ACTIVATION BY CALRETICULIN | Porcellini et al. 
of responding crt−/− versus crt+/+ cells as observed with ex 
vivo–isolated eff  ector–memory cells (Fig. 7 a). Although the 
most common pattern of response observed in CD3ε-stim-
ulated crt+/+ cells was a single [Ca2+]i spike followed by a 
sustained, slowly decreasing phase of [Ca2+]i elevation, repet-
itive [Ca2+]i elevations leading to an oscillatory pattern were 
more frequently detected in crt−/− cells (Fig. 7 b). Indeed, in 
crt−/− clones fewer cells responding to the stimulus with only 
one or two [Ca2+]i spikes were detected over the time frame 
of analysis with respect to crt+/+ clones. Also, cells responding 
to the stimulus with six or more [Ca2+]i spikes were only de-
tected in crt−/− clones (Fig. 7 c). Comparable [Ca2+]i patterns 
were observed when the same T cell clones were stimulated 
with OVA-loaded DCs (not depicted).
Because oscillatory [Ca2+]i elevations effi   ciently induce 
NFAT dephosphorylation and nuclear translocation (13), we 
analyzed NFAT dephosphorylation and nuclear translocation 
in crt−/− as well as crt+/+ T helper clones at diff  erent times 
  after CD3ε stimulation. Of the three calcium-regulated 
NFAT members expressed in T cells (NFAT1, NFAT2, and 
NFAT4), NFAT1 is highly expressed at baseline (35) and its 
activation by TCR signaling is relatively short-lived. In fact, 
the bulk of activated NFAT1 reverts to a phosphorylated, 
cytoplasmic form within a few hours of stimulation (36). This 
eff  ect is mediated by NFAT nuclear export kinases such as 
glycogensynthase kinase-3 (37), which is inhibited in CD3-
stimulated human T cells by CD28 costimulation (38). 30 
min after CD3 cross-linking with avidin, NFAT1 was effi   -
ciently dephosphorylated and translocated to the nucleus in 
both crt+/+ and crt−/− clones. At 3 h after stimulation, in 
crt+/+ cells NFAT1 was found in the cytosol mainly in its 
phosphorylated forms, as described previously (36), whereas 
in crt−/− cells faster migrating dephosphorylated NFAT1 was 
still detectable. At 16 h after stimulation, dephosphorylated 
NFAT1 could be detected in the cytosol only upon pro-
longed exposure of crt−/− blots, but a prominent band corre-
sponding to dephosphorylated NFAT1 was readily detected 
in the nuclear fraction of crt−/− but not crt+/+ T cell clones 
(Fig. 8 a). The prolonged nuclear translocation of NFAT1 in 
crt−/− T helper clones may be the result of diff  erent calcium 
signaling between crt+/+ and crt−/− cells. Stimulation of 
T helper clones with DCs loaded with decreasing doses of 
OVAp revealed in crt−/− cells a dose-dependent decrease in 
NFAT1 nuclear translocation at 16 h after activation, 
whereas the same low amount of NFAT1 was recovered 
from nuclear fractions of crt+/+ cells regardless of the OVAp 
concentration used for stimulation (Fig. 8 b). These data fur-
ther confi  rm the lower threshold of activation in crt−/− cells 
and suggest that CRT defi  ciency positively infl  uences NFAT 
activation after TCR stimulation.
Nuclear translocation of NFAT1 may trigger the tran-
scription of genes involved in T cell activation as well as genes 
leading to tolerance and anergy (39). A requisite for the pro-
ductive immune response consists in the parallel activation 
of mitogen-activated protein kinases (MAPKs), their nuclear 
translocation, and phosphorylation of specifi  c transcription 
factors, which regulate together with NFAT the transcription 
of genes involved in T cell activation. Therefore, we investi-
gated p38MAPK, ERK, and jun phosphorylation in T helper 
clones stimulated with CD3 antibodies. At early time points 
Figure 6.  In vitro and in vivo induction of anergy in crt  −/− CD4 
cells. (a) CFSE dilution in purifi  ed CD4 effector–memory cells treated with 
1 μM ionomycin and then stimulated with CD3ε mAb for 72 h. FACS 
analysis was performed 3 d later. Numbers indicate the absolute values of 
cells recovered within the marker limits in standardized acquisitions. One 
experiment representative of three is shown. (b) Relative [3H]thymidine 
incorporations (left) and IL-2 concentration in culture supernatants 
(right) of effector–memory T cells either untreated or treated with 1 μM 
ionomycin upon stimulation with the CD3ε and CD28 mAbs for 96 h. 
(c) [3H]thymidine incorporation in purifi  ed CD4+ DO11.10tg T cells from 
untreated (ctrl) or OVA-fed chimeras of the indicated genotype stimulated 
for 96 h with DCs loaded with decreasing concentrations of OVAp (top 
panels). The displayed results are representative of three different experi-
ments. Relative [3H]thymidine incorporation (bottom left) and IL-2 concen-
tration in culture supernatants (bottom right) of CD4+ DO11.10tg T cells 
stimulated with DCs loaded with the indicated concentrations of OVAp 
for 96 h. Mean ± SD of three different OVA-fed DO11.10tg crt +/+ (gray 
dashed bars) and crt −/− (black dashed bars) chimeric mice are shown.JEM VOL. 203, February 20, 2006  467
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after stimulation we did not detect diff  erences in the phos-
phorylation intensities (not depicted). However, at 16 h after 
stimulation although c-jun was analogously phosphorylated 
in both crt+/+ and crt−/− clones, more intensely phosphory-
lated p38MAPK and ERK could be detected in crt−/− com-
pared with crt+/+ T helper clones, implying a more sustained 
activation of these MAPK pathways (Fig. 8 c). Collectively, 
these results support the view that CRT critically participates 
in the regulation of TCR-dependent gene transcription dur-
ing an adaptive immune response.
DISCUSSION
CRT is a molecular chaperone and the main Ca2+ buff  ering 
protein in the ER. In vivo as well as in vitro studies with 
crt−/− cells have demonstrated the crucial role of CRT in the 
homeostasis of intracellular Ca2+, thereby regulating signal 
transduction and cell susceptibility to apoptosis (18, 19). 
However, the role CRT might play in TCR-mediated sig-
naling was not investigated so far. Here we showed that 
RAG/γ chain DKO mice reconstituted with crt−/− FLPs dis-
played blepharitis and alopecia, two phenotypic traits that 
were correlated with immunopathological T cell activation 
(40, 41). CRT deletion could also infl  uence the function of 
other immune cells. Indeed, it was shown to bind to the col-
lectin family of molecules (C1q, the fi  rst subcomponent of 
complement, and surfactant proteins A and D; reference 42), 
and this binding was shown to infl  uence infl  ammatory pro-
cesses (43). Recently, CRT at the cell surface was implicated 
in inducing the clearance of apoptotic cells (44). The role of 
T cells in determining the phenotype of crt−/− chimeras was 
supported by the absence of any sign of disease at week 20 af-
ter reconstitution in chimeras generated with crt−/−/cd3ε−/− 
DKO FLPs, in which crt−/− T cells were absent, whereas 
100% of crt−/− chimeras displayed overt immunopathology at 
week 10 after reconstitution. Two crucial mechanisms limit 
the harmful potential of peripheral T cells for the organism; 
namely, the deletion of self-reactive T cells during thymic 
diff   erentiation and the immunosuppressive competence of 
the CD4+CD25+ T reg cell subset. Analysis of apoptosis of 
CD4+8+ DP cells did not reveal an impairment of crt−/− thy-
mocytes to undergo antigen-driven clonal deletion, thereby 
suggesting that tolerance induction through this mechanism 
was not implicated. The capacity of crt−/− T reg cells to in-
hibit a CD3-driven mitogenic response was not impaired, 
ruling out an intrinsic defect of this cell subset in determining 
the immunopathological damage. However, crt−/− CD4 T cells 
were less sensitive to inhibition by T reg cells. Nevertheless, 
antinuclear, anti–double-stranded DNA, and anti-cardiolipin 
Figure 7.  Recurrent calcium elevations in crt  −/− T cell clones. CD4+ 
DO11.10tg T cell clones from crt +/+ and crt −/− chimeras were loaded with 
Fura-2 and monitored for changes in [Ca2+]i. (a) Percentages of crt +/+ 
and crt −/− T cell clones responding with [Ca2+]i elevations upon CD3ε 
stimulation (means ± SD of at least 97 single cells). (b) Temporal analysis 
of [Ca2+]i elevations upon CD3 stimulation of representative crt +/+ and 
crt −/− clones. (c) Relative distributions of cells with respect to numbers of 
[Ca2+]i elevations over 1,100 s. Means ± SD of three independent experi-
ments with two different clones per group. Black bars, crt +/+, n = 89; red 
bars, crt −/−, n = 93.
Figure 8.  Protracted NFAT activation and MAPK signaling in 
crt  −/− T cell clones. (a) Immunoblot analysis of NFAT1 in cytosolic and 
nuclear fractions of crt +/+ and crt −/− DO11.10tg T cell clones stimulated 
with CD3ε mAb for the indicated times. The experiment is representative 
of three different clones per group. (b) Immunoblot of NFAT1 in nuclear 
fractions of crt +/+ and crt −/− DO11.10tg T cell clones stimulated for 16 h 
with DCs loaded with decreasing doses of OVAp. The result is representa-
tive of three experiments with two different clones per group. (c) Immu-
noblot of phosphorylated p38MAPK, ERK, and c-jun in crt +/+ and 
DO11.10tg T cell clones before and 16 h after crt −/− stimulation. The 
result is representative of four different experiments with at least two 
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antibodies were not detected in the sera from crt−/− chimeras, 
suggesting that an autoreactive response was not implicated 
in the observed immunopathology. Analysis of peripheral 
T cell compartments revealed increased frequencies of T cells 
displaying markers of activation and secreting proinfl  amma-
tory cytokines as well as expansion of the CD44+CD62L− 
eff   ector–memory subset in mice reconstituted with crt−/− 
FLPs. Chimeric mice generated with crt−/− DO11.10tg FLPs 
did not display an overt pathological phenotype as “poly-
clonal” mice up to 24 wk after reconstitution. Peripheral 
colonization of lymphopenic hosts by T cells determines ho-
meostatic expansion of positively selected T cells and a pat-
tern of gene expression similar to that of antigen-experienced 
cells (45) with acquisition of the CD44+62L− phenotype 
(46). Because in DO11.10tg mice a fraction of peripheral 
T cells does not express the clonotypic TCR but TCRs with 
diff  erent  specifi   cities, we compared the representation of 
CD44+62L− cells either expressing or not the transgenic 
TCR. Crt−/− and crt+/+ chimeras did not display signifi  cant 
diff  erences in CD44+62L− expression in the clonotype-posi-
tive compartment (crt+/+ = 37.2 ± 11.4%, n = 4; crt−/− = 
38.7 ± 12.2%, n = 4); however, a signifi  cant diff  erence in 
CD44+62L− cell representation was detected in the clono-
type-negative fraction (crt+/+ = 39.0 ± 6.2%, n = 4; crt−/− = 
54.8 ± 7.5%, n = 4, P = 0.006), thereby suggesting that 
CRT deletion altered the T cell response to environmental 
antigens but not homeostatic expansion. Moreover, this indi-
cates that immunopathology in crt−/− chimeras depends on 
hyperresponsiveness to environmental antigens of a physio-
logical peripheral T cell pool. Indeed, antigen priming 
of DO11.10tg crt−/− cells determined exaggerated swelling 
of the draining lymph node as well as more robust cell prolif-
eration and cytokine secretion than observed with the crt+/+ 
counterpart. These results were consistent with the reduced 
apoptosis and increased IL-2 production by suboptimally 
stimulated crt−/− T cells, suggesting that the threshold for 
TCR activation was lowered and persistence of positive sig-
nals was enforced in peripheral T cells by CRT defi  ciency.
Calcium signaling intervenes at multiple stages during 
T cell development in the thymus; e.g., thymocyte β selec-
tion by the pre-TCR (24) and positive as well as negative se-
lection by the αβTCR (25–27). Moreover, the sustained 
[Ca2+]i elevation after TCR triggering of peripheral T cells is 
crucial for the development of the immune response (11). 
CRT defi  ciency aff  ected T cell function manifestly in the 
periphery while thymocyte development appeared unaltered. 
In spite of analogous signal transduction pathways used by 
both immature and mature T cells, the magnitude of the 
[Ca2+]i increase after TCR stimulation is larger in mature 
T cells (references 24 and 25, and unpublished data). We hy-
pothesize that CRT defi  ciency selectively aff  ects Ca2+ signal-
ing when sustained [Ca2+]i elevations are critical in the 
regulation of the T cell response, likely in the peripheral 
T cell upon antigen encounter. After TCR stimulation, we 
observed repetitive [Ca2+]i peaks leading to an oscillatory 
pattern in crt−/− cells, whereas sustained Ca2+ infl  ux predom-
inated in crt+/+ T cells. Similar observations were made in 
Xenopous oocytes, where CRT was proposed to regulate the 
sarco-endoplasmic reticulum calcium transport ATPase 
(SERCA), which pumps Ca2+ from the cytosol into the ER 
lumen, thereby infl  uencing the degree of ER Ca2+ fi  lling 
(47). Indeed, CRT association with SERCA reduced pump 
activity through the recruitment of the ER oxidoreductase 
ERp57 and oxidation of critical ER facing thiol groups of 
SERCA (47, 48). An increased activity of the SERCA pump 
might contribute to the oscillatory [Ca2+]i pattern observed 
in crt−/− T cells.
Magnitude, kinetics, and subcellular location of Ca2+ sig-
nal can all be deciphered by the cell and translated into dis-
tinct responses, thereby conferring specifi  city to an otherwise 
pleiotropic signal (49). Indeed, [Ca2+]i oscillation frequency 
was shown to control the activation of distinct sets of tran-
scription factors and the expression of diff  erent genes (12, 
13). [Ca2+]i spikes elicited by CD3ε antibodies were posi-
tively correlated with NFAT-regulated gene expression (50). 
Recently, oscillatory changes in [Ca2+]i were shown to be 
more effi     cient than a continuous increase in translocating 
NFAT (13). CD3ε stimulation of T cell clones derived from 
DO11.10tg crt−/− chimeric mice resulted in the reduced de-
tection of phosphorylated NFAT1 forms in the cytosol and 
the prominent accumulation of dephosphorylated forms in 
the nucleus, suggesting that the strength of TCR signaling 
was enhanced in crt−/− cells and nuclear export kinase activity 
was inhibited. Similar results were obtained in the same 
clones stimulated with the cognate antigen presented by DCs, 
thus suggesting that enhanced IL-2 secretion in crt−/− cells 
could depend on aberrant NFAT regulation.
The analysis of the T cell response after sustained [Ca2+]i el-
evation by ionomycin treatment revealed the Ca2+-dependent 
up-regulation of genes involved in the targeted proteolysis of 
signaling proteins. This transcriptional program is controlled 
by calcineurin/NFAT activation and induces T cell unrespon-
siveness to TCR stimulation (51). Deletion of these genes in 
mice results in immunopathology, suggesting the physiologi-
cal relevance of such a transcriptional program in T cell ho-
meostasis. Treatment of crt−/− eff  ector–memory T cells with 
ionomycin promoted unresponsiveness to subsequent TCR 
stimulation and OVA feeding of DO11.10tg chimeras pro-
moted ex vivo T cell unresponsiveness of sorted crt−/− CD4+ 
cells, suggesting that CRT defi   ciency was not altering the 
functional effi   ciency of the inhibitory machinery implicated 
in inducing T cell unresponsiveness but maybe interferes with 
its up-regulation after TCR stimulation. CRT could ensure 
the appropriate supply of Ca2+ for the physiological calcium 
response and regulated T cell activation. Interestingly, it was 
shown that calcium restriction in kidney epithelial cells was 
associated with increased B-Raf protein levels and derepressed 
B-Raf/ERK pathways leading to phenotypic remodeling and 
conversion to cell proliferation of otherwise growth-inhibited 
cells (52). The more oscillatory calcium response observed in 
crt−/− cells could result in a diff  erent transcriptional program 
in which activation components would dominate. Positive JEM VOL. 203, February 20, 2006  469
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  regulators of TCR-induced activation include p38MAPK, 
ERK, and jun (53). These proteins were shown to infl  uence 
the NFAT transactivation potential, further contributing to the 
T cell activation genetic program controlled by NFAT (39, 
54, 55). Analysis of p38MAPK, ERK, and jun phosphoryla-
tion after TCR stimulation revealed signifi  cantly protracted 
activation of p38MAPK and ERK in crt−/− clones, implying a 
defective modulation of these T cell activation pathways in the 
absence of CRT. Accordingly, [Ca2+]i oscillations were shown 
to reduce the threshold for Ras activation potentiating ERK 
activation induced by suboptimal agonist concentration (56).
crt−/− chimeras were characterized histologically by normal 
thymus, gut, kidney, liver, and pancreas. Infl  ammatory infi  l-
trates were evident in the skin and in the peribronchial space of 
the lung. Furthermore, IgG1 and IgE levels were signifi  cantly 
increased. These features of crt−/− chimeras are reminiscent of 
NFAT1/4 DKO mice described by Ranger et al. (41), in which 
the unbalanced activation of NFAT2 induced up-regulation 
of Th2-dependent cytokine responses. Another study demon-
strated that NFAT1 and NFAT2 were necessary for TCR-me-
diated T cell eff  ector functions, suggesting that the functions of 
NFAT1 and NFAT2 may be largely redundant in the regula-
tion of most eff  ector cytokines (57) and indicating that NFAT1 
might participate with NFAT2 in the generation of T cell ef-
fector functions. The phenotype of crt−/− chimeras could derive 
from a dominance of Th2 diff  erentiation in vivo resulting from 
hyperresponsiveness to TCR stimulation (58). Indeed, consider-
able amounts of IL-4 were detected in the supernatants of crt−/− 
but not crt+/+ primary T cells stimulated with CD3 and CD28 
antibodies. In conclusion, our study suggests that CRT modu-
lates T cell activation by regulating calcium signaling. CRT de-
fi  ciency results in a lower stimulation threshold, enhanced TCR 
signaling through MAPK pathways, and protracted NFAT ac-
tivation in peripheral T cells, thereby endowing the adaptive 
T cell response with harmful potential for the organism.
MATERIALS AND METHODS
Mice. crt+/− (H-2b) mice (20), BALB/c RAG/γ chain DKO (H-2d) mice 
provided by M. Ito (Central Institute for Experimental Animals, Miyamae, 
Kawasaki, Japan), B6D2F1 (BALB/c × C57BL/6 F1, H2d/b) mice from 
Charles River Germany, and transgenic DO11.10 (H-2d) mice from The 
Jackson Laboratory were bred and treated in accordance with the Swiss Fed-
eral Veterinary Offi   ce guidelines. Experiments were approved by “Diparti-
mento della Sanità e della Socialità.” To generate fetal liver chimera, timed 
pregnant crt+/− female mice were killed at day 13 p.c. and the embryos were 
explanted under sterile conditions (genotype frequencies were as follows: 
crt−/−, 16%; crt+/+, 31%; crt+/−, 53%; n = 553). The following two sets of 
primers were used to screen the progeny: 5′-C  T  C  C  A  G  G  T  C  C  C  C  G  T  A  A-
A  A  T  T  T  G  C  C  -3′ and 5′-A  G  G  T  C  T  A  A  A  C  C  A  G  T  C  A  A  A  A  G  G  A  C  C  -3′ for 
the detection of the crt WT gene and 5′-T  C  G  T  G  C  T  T  T  A  C  G  G  T  A  T  C  G  C-
C  G  C  T  C  C  C  G  A  T  T  -3′ and 5′-C  G  C  G  G  A  T  C  C  A  C  C  T  C  C  C  A  T  G  A  C  A  G  C  C-
A  T  T  T  A  -3′ for identifi  cation of the crt mutant gene. RAG/γ chain DKO 
at 6 wk of age were used as recipients for lymphoid reconstitution. Mice 
were irradiated with 4 Gy from a 137Cs source (Biobeam 8000; STS GmbH) 
at 3.75 Gy/min. Mice were i.v. injected with 2 × 106 fetal liver cells in 
200 μl PBS. TNF-α in sera was quantifi  ed with an ELISA kit (Quanti-
kine; R&D Systems). To generate crt+/−/DO11.10tg mice, crt+/− mice 
were crossed with DO11.10tg mice and the progeny was screened for crt 
mutation as described above and for the TCR transgene with the following 
primers: 5′-C  A  G  G  A  G  G  G  A  T  C  C  A  G  T  G  C  C  A  G  C  -3′ and 5′-T  G  G  C  T  C  T-
A  C  A  G  T  G  A  G  T  T  T  G  G  T  -3′. H-2b/d crt−/− and crt+/+ DO11.10tg embryos 
from F1 intercrosses were identifi  ed for crt and TCR transgene with the 
PCRs described above and for H-2 haplotype by generating DCs from fetal 
livers in the presence of recombinant granulocyte-macrophage colony-stim-
ulating factor (R&D Systems), and by fl  ow cytometry of the in vitro–gener-
ated DCs with CD11c and H-2–specifi  c antibodies.
T cell purifi   cation and proliferation assays. T cells were isolated 
from peripheral lymph nodes and spleens by negative selection with im-
munomagnetic beads followed by cells sorting. Cells were incubated 
with biotin-conjugated anti-CD19, anti-Ter119, anti-panNK, and anti-
CD11b mAbs (eBioscience). T lymphocytes were enriched by remov-
ing biotin-labeled cells bound to streptavidin-conjugated magnetic beads. 
CD4+ naive (CD4+CD44−CD25−CD62L+) and eff  ector–memory 
(CD4+CD44+CD25−CD62L−) T cell subsets were sorted with a FACSAria 
(Becton Dickinson). The cells were labeled with CFSE (Invitrogen) and 
stimulated with 10 μg/ml of plate-bound anti-CD3ε mAb with or without 
5 μg/ml of coimmobilized anti-CD28 mAb (eBioscence). At diff  erent times, 
we transferred eff  ector–memory cells to uncoated wells to terminate TCR 
stimulation and continued cell culture for 96 h in medium alone or in the 
presence of 90 U/ml IL-2, 25 ng/ml IL-7, or 25 ng/ml IL-15, as described 
previously (31). FACS acquisitions were standardized by fi  xed numbers of 
calibration beads (BD Biosciences). IL-2 was measured in supernatants with 
an ELISA kit according to the manufacturer’s instructions (Quantikine; 
R&D Systems). CD4+ naive T cell proliferation was scored on sorted cells 
that were cultured in anti-CD3ε–coated fl  at-bottom microplates at 3 × 104 
cells/well for 96 h. [3H]thymidine (2 μCi/well) was added and the plates 
were harvested after 12 h of incubation. Bone marrow–derived DCs were 
generated from femurs of mice in the presence of recombinant granulo-
cyte-macrophage colony-stimulating factor (R&D Systems). Sorted CD4+ 
naive T cells from DO11.10tg mice were cultured at 10 DO11.10tg cells to 
1 DC ratio with DCs pulsed with various doses of OVA323–339 peptide. For 
adoptive transfer of TCR transgenic cells, spleen and lymph node cells from 
RAG/γ chain DKO chimeric mice reconstituted with either crt+/+ or crt−/− 
DO11.10tg H-2b/d progenitors were labeled with CFSE. Cell suspensions 
containing 106 TCR transgenic cells were i.v. injected into B6D2F1 mice. 
Adoptively transferred mice were immunized s.c. into the footpad 24 or 48 
h later with 2 × 106 DCs pulsed with 2 μM OVA323–339 peptide at 37°C for 
1 h. Popliteal lymph nodes were analyzed at various times after immuniza-
tion for cell number and cytokine secretion by DO11.10tg cells.
T reg cell inhibition assay. CD4+ T reg cells (CD4+CD25+) and 
CD4+ naive T cells (CD4+CD25−CD62L+) were isolated from periph-
eral lymph nodes and spleens by negative selection with immunomagnetic 
beads followed by cell sorting as described above. Naive CD4+ T cell 
were cocultured in 96-well round-bottom plates at 50,000 cells/well with 
serial dilutions of T reg cells (from 1:1 to 1:64) in the presence of 5,000 
DCs/well and with 0.2 μg/ml anti-CD3ε mAb. After 48 h of incubation 
[3H]thymidine (2 μCi/well) was added and the plates were harvested after 
12 h of incubation.
Biochemical procedures. CD4+ DO11.10tg T cell clones were generated 
from the spleens of crt−/− and crt+/+ DO11.10tg chimeras by stimulation 
with OVAp-loaded DCs. They were restimulated with OVAp-loaded DCs 
every 14 d. For CD3 stimulation, clones at days 10–13 from restimulation 
were incubated for 30 min at room temperature with 1 μg/ml biotinylated 
CD3ε mAb (clone 145-2C11) in cell culture medium. Unbound antibody 
was removed by centrifugation and the cells were resuspended in medium 
containing 1 μg/ml avidin for 30 min to 16 h as indicated in Results. In 
some experiments, T cell clones were stimulated with OVAp-loaded DCs at 
a ratio of 20:1. For biochemical analysis, cells were washed twice in PBS and 
lysed in a hypo-osmotic buff  er (10 mM Hepes, 1.5 mM MgCl2, 10 mM KCl, 
0.05% NP-40, and protease inhibitors) for 10 min on ice. The nuclei were 
separated from the cytosolic fraction by a 10-min centrifugation at 2,000 g. 
Samples were analyzed by SDS PAGE followed by immunoblot. NFAT1 470  REGULATION OF T CELL ACTIVATION BY CALRETICULIN | Porcellini et al. 
antibodies were provided by N.R. Rice (NCI-Frederick Cancer Research 
and Development Center, Frederick, MD), phospho-p38 MAPK (3D7) and 
phospho-ERK (197G2) rabbit mAbs were from Cell Signaling Technology, 
phospho-c-jun (KM-1) mouse mAb was from Santa Cruz Biotechnology, 
Inc., and β actin mouse mAb (A-5441) was from Sigma-Aldrich.
Online supplemental material. Supplemental Results and Figs. S1 and 
S2 show unaltered pre-TCR signaling as well as unaltered positive se-
lection and deletion of crt−/− thymocytes. Supplemental Materials and 
methods describe the detection of autoantibodies, mAbs used in fl  ow cy-
tometry, induction of anergy, and calcium imaging. Supplemental Results,
Materials and methods, and Fig. S1 are available at http://www.jem.org/
cgi/content/full/jem.20051519/DC1.
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